New York, NY · Founded 2022 · Privately Held (backing)
Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments. Conceivable Life Sciences is based in New York, NY and was founded in 2022. It was valued at $145 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $88.5 million across 3 recorded rounds; the latest was a $30.5 million early-stage round in Aug 2025.
PMV mark · valuation
$145.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$88.5M
Last round
Early Stage VC
Aug 2025
Cap table — not yet on record
Conceivable Life Sciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Conceivable Life Sciences with a free account
·The complete investor list: 13 names
·Watch Conceivable Life Sciences: the Monday email on marks, rounds and moves
Where does Conceivable Life Sciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Conceivable Life Sciences's 3 recorded funding rounds.
